Healthcare Alliance Inc
⚠️ High Risk
FEI: 3003500903 • Woodbridge, ON • CANADA
FEI Number
3003500903
Location
Woodbridge, ON
Country
CANADAAddress
95 Whitmore Road #2, , Woodbridge, ON, Canada
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
AGR RX
The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/26/2001 | 61LCY38CLOPIDOGREL BISULFATE (ANTI-COAGULANT) | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 66NCY02OLANZAPINE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 66NCY02OLANZAPINE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 66NCY02OLANZAPINE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 62BCA99ANTI-HYPERLIPIDEMIC N.E.C. | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 61NCY99ANTI-DEPRESSANT N.E.C. | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 61NCY99ANTI-DEPRESSANT N.E.C. | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 61NCY99ANTI-DEPRESSANT N.E.C. | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 61FCY55CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC) | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 61NCY99ANTI-DEPRESSANT N.E.C. | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 61NCY69GABAPENTIN (ANTI-DEPRESSANT) | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 61NCY69GABAPENTIN (ANTI-DEPRESSANT) | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 61JCY99ANTI-CHOLESTEREMIC, N.E.C. | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 61JCY99ANTI-CHOLESTEREMIC, N.E.C. | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 60LCY83CELECOXIB (ANALGESIC) | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 62TCY02LANSOPRAZOLE (ANTI-SECRETORY) | Cincinnati District Office (CIN-DO) | |
| 12/26/2001 | 62GCY99ANTI-INFLAMMATORY N.E.C. | 179AGR RX | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is Healthcare Alliance Inc's FDA import refusal history?
Healthcare Alliance Inc (FEI: 3003500903) has 19 FDA import refusal record(s) in our database, spanning from 12/26/2001 to 12/26/2001.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Healthcare Alliance Inc's FEI number is 3003500903.
What types of violations has Healthcare Alliance Inc received?
Healthcare Alliance Inc has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Healthcare Alliance Inc come from?
All FDA import refusal data for Healthcare Alliance Inc is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.